Vivimed Labs (NSE:VIVIMEDLAB) Total Liabilities: ₹0.0 Mil (As of Dec. 2025)


NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
38 GF Score
Price ₹5.80
GF Value ₹2.56
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs Total Liabilities?

Vivimed Labs NSE:VIVIMEDLAB -3.17% 38 Total Liabilities is ₹0.0 Mil as of Dec. 2025. GuruFocus rates NSE:VIVIMEDLAB with a GF Score™ of 38/100 and a GF Value™ of ₹2.56 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Vivimed Labs's Total Liabilities for the quarter that ended in Dec. 2025 was ₹0.0 Mil.

Vivimed Labs's quarterly Total Liabilities increased from Jun. 2025 (₹0.00 Mil) to Sep. 2025 (₹9,719.57 Mil) but then declined from Sep. 2025 (₹9,719.57 Mil) to Dec. 2025 (₹0.00 Mil).

Vivimed Labs's annual Total Liabilities increased from Mar. 2023 (₹9,556.28 Mil) to Mar. 2024 (₹9,563.72 Mil) but then declined from Mar. 2024 (₹9,563.72 Mil) to Mar. 2025 (₹9,560.03 Mil).

Vivimed Labs Total Liabilities Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs Total Liabilities Chart

Vivimed Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,577.54 9,017.30 9,556.28 9,563.72 9,560.03

Vivimed Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 9,560.03 0.00 9,719.57 0.00
NSE:VIVIMEDLAB
38GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vivimed Labs's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4081.98+(636.15+139.62
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+4702.28)
=9,560.0

Total Liabilities=Total Assets (A: Mar. 2025 )-Total Equity (A: Mar. 2025 )
=9208.34--351.69
=9,560.0

Vivimed Labs's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+4702.28)
=N/A

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹0.0 Mil mean?
Vivimed Labs (NSE:VIVIMEDLAB) has a Total Liabilities of ₹0.0 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vivimed Labs and its competitors.
Is Vivimed Labs' Total Liabilities too high?
Vivimed Labs' current Total Liabilities is ₹0.0 Mil. Overall, Vivimed Labs has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vivimed Labs' Total Liabilities compare to ZTS and UTHR?
Vivimed Labs' Total Liabilities of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vivimed Labs and its competitors. Vivimed Labs's current Total Liabilities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivimed Labs stock overvalued right now?
Based on GuruFocus' analysis, Vivimed Labs (NSE:VIVIMEDLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.56, compared to a current price of ₹5.80 — trading 126.6% above its estimated fair value. The current Total Liabilities is ₹0.0 Mil. Vivimed Labs' overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Vivimed Labs (NSE:VIVIMEDLAB), the current Total Liabilities is ₹0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.80 is trading 126.6% above its estimated GF Value™ of ₹2.56. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • Total Liabilities: ₹0.0 Mil
  • GF Value™: ₹2.56 vs. price of ₹5.80 (126.6% above fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
38GF Score

Get the complete analysis for NSE:VIVIMEDLAB

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.80
Price
₹2.56
GF Value